Status:
UNKNOWN
Monitoring and Self-management of Sleep Fatigue and Dyspnea
Lead Sponsor:
University of Massachusetts, Amherst
Conditions:
Heart Failure Patients
Eligibility:
All Genders
30-85 years
Phase:
NA
Brief Summary
African Americans have the highest risk for developing heart failure. When African Americans are diagnosed with heart failure (AAHF) it is usually more advanced HF compared to other races. African-Ame...
Detailed Description
Symptoms of heart failure due to circulatory fluid overload: Signs of circulatory fluid overload are theleading to cardiac decompensation or worsening heart failure are: orthopnea, dyspnea, fatigue, w...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age 30-85years.
- Diagnosis of heart failure based on patient's medical record.
- Meets the criteria for New York Heart Failure (NYHF) classification for stage I-III heart failure.
- Meets the criteria for ACA/AHA HF classification Stage A and B (Patient with clinical HF).
- Exclusion Criteria
- Exclusion criteria include patients with a diagnosis of dementia, patients on the heart transplant
- list and stage IV HF.
Exclusion
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04434716
Start Date
August 15 2019
End Date
April 30 2021
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Amherst
Amherst, Massachusetts, United States, 01003